Our commitment to fight the pandemic.
Project Title: Development of a multiplex assay to determine SARS-CoV-2 strains and specific antibody-producing transcripts (CoVplex).
The CoVplex project is a joint project with the University of Malta and aims to measure and study the immune response by the human body following SARS-CoV-2 (COVID-19) infection. The project aims to identify individuals that generate antibodies that neutralise the virus and use this information to develop a simple blood test to measure effective immunity. The innovative test will have an impact on vaccine surveillance (effectiveness of vaccination program).
To synergise the advantages of microfluidics, and multiplex bead based assays, to measure biomarkers in blood-derived exosomes
Innovative molecular profiling assays to classify tumours. We developed multiplex assays for academic research and lab based testing programs.
To innovate a companion diagnostic product that predicts use of specific therapeutics in Epilepsy.